India's Pharmaceutical Exports

Country Profile

Kuwait

Kuwait is an emerging destination for Indian pharmaceutical exports — $13.5M in FY 2025–26, with 2.7× growth over the past decade. Medicines accounts for 68% of shipments, with vaccines contributing $225K. The compound annual growth rate since FY2015 stands at 9.6%.

🇰🇼 $13.5M · 2.7× growth since FY2015 · 9.6% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$13.5M
Exports FY2025–26 DGCIS
2.7×
Growth FY2015→2026
9.6%
CAGR FY2015→2026
68%
Medicines Share
5
Product Categories Supplied
Kuwait is an emerging destination for Indian pharmaceutical exports — $13.5M in FY 2025–26, with 2.7× growth over the past decade. Medicines accounts for 68% of shipments, with vaccines contributing $225K. The compound annual growth rate since FY2015 stands at 9.6%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $9.17M (67.8%) Traditional & Herbal $2.18M (16.1%) Medicine Ingredients $1.51M (11.2%) Surgical & Hospital Supplies $431K (3.2%) Vaccines $225K (1.7%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Kuwait in the RBI overseas direct investment dataset (2011–2026).